RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is the third most deadly and fourth most diagnosed cancer worldwide. Despite the progress in early diagnosis and advanced therapeutic options, CRC shows a poor prognosis with a 5 year survival rate of ~ 45%. PRDM2/RIZ, a member of PR/SET domain family (PRDM), expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Donato, Marzia, Di Zazzo, Erika, Salvati, Annamaria, Sorrentino, Carmela, Giurato, Giorgio, Fiore, Donatella, Proto, Maria Chiara, Rienzo, Monica, Casamassimi, Amelia, Gazzerro, Patrizia, Bifulco, Maurizio, Castoria, Gabriella, Weisz, Alessandro, Nassa, Giovanni, Abbondanza, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585774/
https://www.ncbi.nlm.nih.gov/pubmed/37853459
http://dx.doi.org/10.1186/s12967-023-04621-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585774/
https://www.ncbi.nlm.nih.gov/pubmed/37853459
http://dx.doi.org/10.1186/s12967-023-04621-6

Ejemplares similares